Clinical trial
Betamethason Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis
NCT02604537 is registered in ClinicalTrials.gov with OrthoCarolina Research Institute, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Betamethason Versus Ketorolac Injection for the Treatment of DeQuervains Tenosynovitis
- Lead sponsor
- OrthoCarolina Research Institute, Inc.
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 15, 2015
- Completion date
- October 30, 2024
- Enrollment
- 62 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dequervain tendinopathy